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INTRODUCTION: Prior to new material or drug 
use in humans, a series of preclinical and clinical 
tests to determine compatibility with human 
subjects must be passed1. Tissue engineered 
constructs allow for high throughput testing in a 
tightly controlled environment whilst maintaining 
strong mimicry of in vivo architecture. However, 
this is often costly in terms of resources and cell 
numbers. Therefore, it was sought to optimise the 
manufacturing variables to limit use of resources 
whilst maintaining characteristics of the in vivo 
tissue. This work proposes that variation in cell 
density (2, 3 and 4 million cells/mL) and 
alterations in attachment forces governed by gel 
width and surface area of attachment will regulate 
the formation and maturation of tissue engineered 
skeletal muscle constructs.  
METHODS: 3D type-1 rat-tail collagen 
(2.20mg/mL) neutralised constructs were seeded 
with C2C12 murine myoblast cells as previously 
described3. The constructs were tethered at either 
end by bespoke polythene mesh floatation bars to 
create longitudinal lines of isometric tension (Fig 
1). Constructs were placed in 20% FBS high 
glucose DMEM for 4 days and then cultured in 2% 
horse serum high glucose DMEM to induce 
differentiation. Preclinical work relies on high 
numbers of replicates; therefore, this study is 
conducted in a scaled down model (0.3mL-0.8mL) 
to reduce resource use whilst maintaining basic 
characteristics of the previous model3 (3mL total 
volume) 
 
RESULTS: Variation between 2, 3 and 4 million 
cells/mL of collagen and construct designs 
(volume and attachment area variation) had no 
significant effect on contraction time or width 
reduction (ANOVA P>0.05). Preliminary analysis 
indicates that the width of the construct has an 
effect on alignment and higher cell densities 
produce greater alignment. Physical success of the 
muscle construct with an extension past the anchor 
point is 30% greater than without [~100% (n=6) 
vs. ~70% (n=6)]. High cell densities displayed 
greater number of unattached cells. 
Immunohistochemical staining for the intermediate 
filament protein Desmin showed the capacity for 
alignment and differentiation of C2C12 myoblasts 
within the collagen system (Fig. 2). 
  
Fig. 1 Muscle construct variables: Observed 
effects of initial width past anchor point and cell 
density. (left) Day 0 (right) Day 14  (top),  
4million cells/mL (0.8ml, ~15mm initial width)  
(bottom) 2million cells/mL (0.3mL ~5mm initial 
width) 
  
Fig. 2.  Immunohistochemistry shows Desmin 
intermediate filament (red) and DAPI nuclear stain 
(blue) (40x magnification). 
DISCUSSION & CONCLUSIONS: 
The optimum extension lies between 0%-50% of 
the anchor point width based on alignment and 
physical success of the construct. This data 
replicates published work in a similar model3 
whilst expanding previous alignment data4. 
Further phenotypic and genotypic analysis is to be 
completed. 
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